bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Tables from Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
Authors: Boeri Mattia , Milione Massimo , Proto Claudia , Signorelli Diego , Lo Russo Giuseppe , Galeone Carlotta , Verri Carla , Mensah Mavis , Centonze Giovanni , Martinetti Antonia , Sottotetti Elisa , Pastorino Ugo , Garassino Marina Chiara , Sozzi Gabriella
Published: April 2023

Supplementary Table S1, Table S2 and Table S3
Figure S7 from Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability
Authors: Murga-Zamalloa Carlos , Rolland Delphine C.M. , Polk Avery , Wolfe Ashley , Dewar Hiran , Chowdhury Pinki , Onder Ozlem , Dewar Rajan , Brown Noah A. , Bailey Nathanael G. , Inamdar Kedar , Lim Megan S. , Elenitoba-Johnson Kojo S.J. , Wilcox Ryan A.
Published: April 2023

Proposed model for oncogenic activity of CSF1R.
Figure S6 from Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability
Authors: Murga-Zamalloa Carlos , Rolland Delphine C.M. , Polk Avery , Wolfe Ashley , Dewar Hiran , Chowdhury Pinki , Onder Ozlem , Dewar Rajan , Brown Noah A. , Bailey Nathanael G. , Inamdar Kedar , Lim Megan S. , Elenitoba-Johnson Kojo S.J. , Wilcox Ryan A.
Published: April 2023

Pathways regulates downstream of CSF1R inhibition.
Supplementary Data from Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma
Authors: Gerstner Elizabeth R. , Emblem Kyrre E. , Chang Ken , Vakulenko-Lagun Bella , Yen Yi-Fen , Beers Andrew L. , Dietrich Jorg , Plotkin Scott R. , Catana Ciprian , Hooker Jacob M. , Duda Dan G. , Rosen Bruce , Kalpathy-Cramer Jayashree , Jain Rakesh K. , Batchelor Tracy
Published: April 2023

Figure, Table, and MRI acquisition protocol
Figure S4 from Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability
Authors: Murga-Zamalloa Carlos , Rolland Delphine C.M. , Polk Avery , Wolfe Ashley , Dewar Hiran , Chowdhury Pinki , Onder Ozlem , Dewar Rajan , Brown Noah A. , Bailey Nathanael G. , Inamdar Kedar , Lim Megan S. , Elenitoba-Johnson Kojo S.J. , Wilcox Ryan A.
Published: April 2023

CSF1R inhibition with pexidartinib in T-cell lymphoma lines
Supplementary Tables from TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem–Like Cells in a Redox-Sensitive Manner
Authors: Sharif Tanveer , Dai Cathleen , Martell Emma , Ghassemi-Rad Mohammad Saleh , Hanes Mark Robert , Murphy Patrick J. , Kennedy Barry E. , Venugopal Chitra , Subapanditha Minomi , Giacomantonio Carman A. , Marcato Paola , Singh Sheila K. , Gujar Shashi
Published: April 2023

Supplementary Tables
Figure S1 from Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response
Authors: Payen Thomas , Oberstein Paul E. , Saharkhiz Niloufar , Palermo Carmine F. , Sastra Stephen A. , Han Yang , Nabavizadeh Alireza , Sagalovskiy Irina R. , Orelli Barbara , Rosario Vilma , Desrouilleres Deborah , Remotti Helen , Kluger Michael D. , Schrope Beth A. , Chabot John A. , Iuga Alina C. , Konofagou Elisa E. , Olive Kenneth P.
Published: April 2023

Figure S1
Supplementary Data from Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
Authors: Azmi Asfar S. , Khan Husain Yar , Muqbil Irfana , Aboukameel Amro , Neggers Jasper E. , Daelemans Dirk , Mahipal Amit , Dyson Gregory , Kamgar Mandana , Al-Hallak Mohammad Najeeb , Tesfaye Anteneh , Kim Steve , Shidham Vinod , M. Mohammad Ramzi , Philip Philip A.
Published: April 2023

Legends to supplementary Figure
Supplementary Table from Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes
Authors: Alatrash Gheath , Qiao Na , Zhang Mao , Zope Madhushree , Perakis Alexander A. , Sukhumalchandra Pariya , Philips Anne V. , Garber Haven R. , Kerros Celine , St. John Lisa S. , Khouri Maria R. , Khong Hiep , Clise-Dwyer Karen , Miller Leonard P. , Wolpe Steve , Overwijk Willem W. , Molldrem Jeffrey J. , Ma Qing , Shpall Elizabeth J. , Mittendorf Elizabeth A.
Published: April 2023

Supplementary Table
Figure from Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma
Authors: Alrasheed Nouf , Lee Lydia , Ghorani Ehsan , Henry Jake Y. , Conde Lucia , Chin Melody , Galas-Filipowicz Daria , Furness Andrew J.S. , Chavda Selina J. , Richards Huw , De-Silva Dunnya , Cohen Oliver C. , Patel Dominic , Brooks Anthony , Rodriguez-Justo Manuel , Pule Martin , Herrero Javier , Quezada Sergio A. , Yong Kwee L.
Published: April 2023

Supplementary tables and figures
Figure S7 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Authors: House Imran G. , Savas Peter , Lai Junyun , Chen Amanda X.Y. , Oliver Amanda J. , Teo Zhi L. , Todd Kirsten L. , Henderson Melissa A. , Giuffrida Lauren , Petley Emma V. , Sek Kevin , Mardiana Sherly , Gide Tuba N. , Quek Camelia , Scolyer Richard A. , Long Georgina V. , Wilmott James S. , Loi Sherene , Darcy Phillip K. , Beavis Paul A.
Published: April 2023

Figure S7 shows the gene expression profile of macrophages and other immune cell subsets in cancer patients
Figure S6 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Authors: House Imran G. , Savas Peter , Lai Junyun , Chen Amanda X.Y. , Oliver Amanda J. , Teo Zhi L. , Todd Kirsten L. , Henderson Melissa A. , Giuffrida Lauren , Petley Emma V. , Sek Kevin , Mardiana Sherly , Gide Tuba N. , Quek Camelia , Scolyer Richard A. , Long Georgina V. , Wilmott James S. , Loi Sherene , Darcy Phillip K. , Beavis Paul A.
Published: April 2023

Figure S6 shows the phenotype and expression of CXCL9 and CXCL10 by tumor-infiltrating immune cells following treatment with anti-PD-1 and anti-CTLA-4
Table S5 from Genetic Ancestry–dependent Differences in Breast Cancer–induced Field Defects in the Tumor-adjacent Normal Breast
Authors: Nakshatri Harikrishna , Kumar Brijesh , Burney Heather N. , Cox Mary L. , Jacobsen Max , Sandusky George E. , D'Souza-Schorey Crislyn , Storniolo Anna Maria V.
Published: April 2023

Paired Differences between Tumor and NAT
Table S2 from Genetic Ancestry–dependent Differences in Breast Cancer–induced Field Defects in the Tumor-adjacent Normal Breast
Authors: Nakshatri Harikrishna , Kumar Brijesh , Burney Heather N. , Cox Mary L. , Jacobsen Max , Sandusky George E. , D'Souza-Schorey Crislyn , Storniolo Anna Maria V.
Published: April 2023

Descriptive Statistics for the Combined African American and Caucasian Data of their tumors
Figure S1 from Genetic Ancestry–dependent Differences in Breast Cancer–induced Field Defects in the Tumor-adjacent Normal Breast
Authors: Nakshatri Harikrishna , Kumar Brijesh , Burney Heather N. , Cox Mary L. , Jacobsen Max , Sandusky George E. , D'Souza-Schorey Crislyn , Storniolo Anna Maria V.
Published: April 2023

Ancestry marker distribution pattern and MSRB3 expression levels
Supplementary Table S3 from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Authors: Kwon Minsuk , Kim Chang Gon , Lee Hoyoung , Cho Hyunsoo , Kim Youngun , Lee Eung Chang , Choi Seong Jin , Park Junsik , Seo In-Ho , Bogen Bjarne , Song Ik-Chan , Jo Deog-Yeon , Kim Jin Seok , Park Su-Hyung , Choi Inhak , Choi Yoon Seok , Shin Eui-Cheol
Published: April 2023

Supplementary Table S3
Supplementary Table S2 from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Authors: Kwon Minsuk , Kim Chang Gon , Lee Hoyoung , Cho Hyunsoo , Kim Youngun , Lee Eung Chang , Choi Seong Jin , Park Junsik , Seo In-Ho , Bogen Bjarne , Song Ik-Chan , Jo Deog-Yeon , Kim Jin Seok , Park Su-Hyung , Choi Inhak , Choi Yoon Seok , Shin Eui-Cheol
Published: April 2023

Supplementary Table S2
Supplementary Tables 1-14 from Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers
Authors: Gay Carl M. , Tong Pan , Cardnell Robert J. , Sen Triparna , Su Xiao , Ma Jun , Bara Rasha O. , Johnson Faye M. , Wakefield Chris , Heymach John V. , Wang Jing , Byers Lauren A.
Published: April 2023

Supplementary Table S1: Shared mRNA biomarkers predicting PI3K inhibitor sensitivity in SCLC; Supplementary Table S2: Shared protein biomarkers predicting PI3K inhibitor sensitivity in SCLC; Supplementary Table S3: Shared mRNA biomarkers predicting AURKA inhibitor sensitivity in SCLC; Supplementary Table S4: Shared protein biomarkers predicting AURKA inhibitor sensitivity in SCLC; Supplementary Table S5: Shared mRNA biomarkers predicting obatoclax sensitivity in LUAD and SCLC; Supplementary Table S6: DISARM-selected candidates from GDSC for cisplatin-resistant BLCA; Supplementary Table S7: DISARM-selected candidates from GDSC for cisplatin-resistant COAD; Supplementary Table S8: DISARM-selected candidates from GDSC for cisplatin-resistant ESCA; Supplementary Table S9: DISARM-selected candidates from GDSC for cisplatin-resistant HNSC; Supplementary Table S10: DISARM-selected candidates from GDSC for cisplatin-resistant LUAD; Supplementary Table S11: DISARM-selected candidates from GDSC for cisplatin-resistant OV; Supplementary Table S12: DISARM-selected candidates from GDSC for cisplatin-resistant PAAD; Supplementary Table S13: DISARM-selected candidates from GDSC for cisplatin-resistant SCLC; Supplementary Table S14: DISARM-selected candidates from GDSC for cisplatin-resistant STAD.
Supplementary Table S1 from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
Authors: Kwon Minsuk , Kim Chang Gon , Lee Hoyoung , Cho Hyunsoo , Kim Youngun , Lee Eung Chang , Choi Seong Jin , Park Junsik , Seo In-Ho , Bogen Bjarne , Song Ik-Chan , Jo Deog-Yeon , Kim Jin Seok , Park Su-Hyung , Choi Inhak , Choi Yoon Seok , Shin Eui-Cheol
Published: April 2023

Supplementary Table S1
Table S2-S11 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
Authors: Su Zhe , Wang Zhijie , Ni Xiaohui , Duan Jianchun , Gao Yan , Zhuo Minglei , Li Ruoyan , Zhao Jun , Ma Qi , Bai Hua , Chen Hengyu , Wang Shuhang , Chen Xixi , An Tongtong , Wang Yuyan , Tian Yanhua , Yu Jiangyong , Wang Di , Xie Xiaoliang Sunney , Bai Fan , Wang Jie
Published: April 2023

Supplementary Tables 2-11
Figure S1, Figure S2 from A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma
Authors: Goyal Lipika , Zheng Hui , Abrams Thomas A. , Miksad Rebecca , Bullock Andrea J. , Allen Jill N. , Yurgelun Matthew B. , Clark Jeffrey W. , Kambadakone Avinash , Muzikansky Alona , Knowles Michelle , Galway Aralee , Afflitto Anthony J. , Dinicola Caroline F. , Regan Eileen , Hato Tai , Mamessier Emilie , Shigeta Kohei , Jain Rakesh K. , Duda Dan G. , Zhu Andrew X.
Published: April 2023

Figure S1 is a schematic of lymphocytes shown as CD3+ cells against side scatter (SSC). Figure S2 is a Kaplan-Meier time-to-progression graph.
Supplementary Figure S1 from Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy
Authors: Schug Christina , Kitzberger Carolin , Sievert Wolfgang , Spellerberg Rebekka , Tutter Mariella , Schmohl Kathrin A. , Eberlein Bernadette , Biedermann Tilo , Steiger Katja , Zach Christian , Schwaiger Markus , Multhoff Gabriele , Wagner Ernst , Nelson Peter J. , Spitzweg Christine
Published: April 2023

Supplementary Figure S1. Cell viability after EW-7197 treatment. The viability of SMAD-NIS-MSCs was not affected by treatment with different concentrations of the selective TGFB signaling inhibitor EW-7197 with or without 10 ng/ml TGFB1 for 24 h as determined by MTT assay. Data are presented as percent of untreated controls from four independent experiments (means {plus minus} SEM).
Table S2 from Metformin Abrogates Age-Associated Ovarian Fibrosis
Authors: McCloskey Curtis W. , Cook David P. , Kelly Brendan S. , Azzi Feryel , Allen Christian H. , Forsyth Amanda , Upham Jeremy , Rayner Katey J. , Gray Douglas A. , Boyd Robert W. , Murugkar Sangeeta , Lo Bryan , Trudel Dominique , Senterman Mary K. , Vanderhyden Barbara C.
Published: April 2023

Gene ontology features in metformin vs. non-fibrotic human ovaries
Supplementary Data from Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome–Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
Authors: Hijiya Nobuko , Zwaan C. Michel , Rizzari Carmelo , Foà Robin , Abbink Floor , Lancaster Donna , Landman-Parker Judith , Millot Frédéric , Moppett John , Nelken Brigitte , Caterina Putti Maria , Tian Xianbin , Sinclair Karen , Santanastasio Helene , Buchbinder Aby , Kearns Pamela
Published: April 2023

Appendix
Figure S3 from Metformin Abrogates Age-Associated Ovarian Fibrosis
Authors: McCloskey Curtis W. , Cook David P. , Kelly Brendan S. , Azzi Feryel , Allen Christian H. , Forsyth Amanda , Upham Jeremy , Rayner Katey J. , Gray Douglas A. , Boyd Robert W. , Murugkar Sangeeta , Lo Bryan , Trudel Dominique , Senterman Mary K. , Vanderhyden Barbara C.
Published: April 2023

Differential gene expression in non-fibrotic, fibrotic, and metformin ovaries with samples from women taking gliptins omitted.
Table S1 from The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma
Authors: Buhl Juliane L. , Selt Florian , Hielscher Thomas , Guiho Romain , Ecker Jonas , Sahm Felix , Ridinger Johannes , Riehl Dennis , Usta Diren , Ismer Britta , Sommerkamp Alexander C. , Martinez-Barbera J.P. , Wefers Annika K. , Remke Marc , Picard Daniel , Pusch Stefan , Gronych Jan , Oehme Ina , van Tilburg Cornelis M. , Kool Marcel , Kuhn Daniela , Capper David , von Deimling Andreas , Schuhmann Martin U. , Herold-Mende Christel , Korshunov Andrey , Brummer Tilman , Pfister Stefan M. , Jones David T.W. , Witt Olaf , Milde Till
Published: April 2023

Primers and antibodies
Figure S1, Figure S2, Figure S3, Figure S4 from The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma
Authors: Buhl Juliane L. , Selt Florian , Hielscher Thomas , Guiho Romain , Ecker Jonas , Sahm Felix , Ridinger Johannes , Riehl Dennis , Usta Diren , Ismer Britta , Sommerkamp Alexander C. , Martinez-Barbera J.P. , Wefers Annika K. , Remke Marc , Picard Daniel , Pusch Stefan , Gronych Jan , Oehme Ina , van Tilburg Cornelis M. , Kool Marcel , Kuhn Daniela , Capper David , von Deimling Andreas , Schuhmann Martin U. , Herold-Mende Christel , Korshunov Andrey , Brummer Tilman , Pfister Stefan M. , Jones David T.W. , Witt Olaf , Milde Till
Published: April 2023

Figure S1: Markers of OIS in murine PA model Figure S2: Viability of DKFZ-BT66 cells under rIL1B treatment Figure S3: SASP factor protein levels in primary PAs Figure S4: Treatments of astrocytes with senolytic agents and combinations treatments of ABT-737 in DKFZ-BT66 cells
Supplementary Table 1 from Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes
Authors: Hammerl Dora , Massink Maarten P.G. , Smid Marcel , van Deurzen Carolien H.M. , Meijers-Heijboer Hanne E.J. , Waisfisz Quinten , Debets Reno , Martens John W.M.
Published: April 2023

Supplementary Table 1. Clinical characteristics of Cohort A per molecular subtype.
Figure S8 from Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
Authors: Chen Xiaoji , Chang Ching-Wei , Spoerke Jill M. , Yoh Kathryn E. , Kapoor Vidushi , Baudo Charles , Aimi Junko , Yu Mamie , Liang-Chu May M.Y. , Suttmann Rebecca , Huw Ling-Yuh , Gendreau Steven , Cummings Craig , Lackner Mark R.
Published: April 2023

Baseline and on-treatment CNV landscapes of patients treated with pictilisib. Somatic variants significantly increased in EOT compared to baseline.
Figure S6 from Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes
Authors: Hammerl Dora , Massink Maarten P.G. , Smid Marcel , van Deurzen Carolien H.M. , Meijers-Heijboer Hanne E.J. , Waisfisz Quinten , Debets Reno , Martens John W.M.
Published: April 2023

Figure S6. Mutations or down-regulated expression of antigen processing and presentation genes in BC subtypes. A, Expression of genes related to APP. B, Proportion of BC patients with one or more mutations in APP genes. Statistical differences were calculated using Kruskal-Wallis test among subtypes, and Wilcoxon rank sum test for pairwise comparison relative to basal-like BC; p-values are indicated as: '***'<0.001, '**'<0.01, '*'<0.05.
Figure S6 from Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
Authors: Chen Xiaoji , Chang Ching-Wei , Spoerke Jill M. , Yoh Kathryn E. , Kapoor Vidushi , Baudo Charles , Aimi Junko , Yu Mamie , Liang-Chu May M.Y. , Suttmann Rebecca , Huw Ling-Yuh , Gendreau Steven , Cummings Craig , Lackner Mark R.
Published: April 2023

Survival and demographic analysis with cfDNA tumor fraction.
Figure S3 from Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes
Authors: Hammerl Dora , Massink Maarten P.G. , Smid Marcel , van Deurzen Carolien H.M. , Meijers-Heijboer Hanne E.J. , Waisfisz Quinten , Debets Reno , Martens John W.M.
Published: April 2023

Figure S3. Correlations between proportions of immune cell populations and TIL score in BC. Scatter plots with correlations (blue lines) between fractions of immune cell subsets and TIL-scores (only displayed when pearson-correlation was significant, p<0.05).
Figure S4 from Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
Authors: Chen Xiaoji , Chang Ching-Wei , Spoerke Jill M. , Yoh Kathryn E. , Kapoor Vidushi , Baudo Charles , Aimi Junko , Yu Mamie , Liang-Chu May M.Y. , Suttmann Rebecca , Huw Ling-Yuh , Gendreau Steven , Cummings Craig , Lackner Mark R.
Published: April 2023

Comparison of CNV landscapes in tumor tissue and cfDNA of the FIGARO squamous NSCLC patients.
Figure S2 from Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes
Authors: Hammerl Dora , Massink Maarten P.G. , Smid Marcel , van Deurzen Carolien H.M. , Meijers-Heijboer Hanne E.J. , Waisfisz Quinten , Debets Reno , Martens John W.M.
Published: April 2023

Figure S2. Scatterplots with pearson correlations (blue lines) between immune cell densities (cells/μm2) of A, CD8 T cells (identified as CD3+ CD8+); B, CD4 T cells (CD3+ CD8-) or C, macrophages (CD68+) and TIL scores in 30 BC patients.
Figure S1 from Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes
Authors: Hammerl Dora , Massink Maarten P.G. , Smid Marcel , van Deurzen Carolien H.M. , Meijers-Heijboer Hanne E.J. , Waisfisz Quinten , Debets Reno , Martens John W.M.
Published: April 2023

Figure S1. Hormone receptor status per BC molecular subtype. Stacked bar-plots show percentage or estrogen receptor (ER, left), progesterone receptor (PR, middle) and human-epidermal growth factor receptor (Her2, right) as assessed by immune histochemistry of the same patients, per BC subtype.
Figure S2 from Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
Authors: Chen Xiaoji , Chang Ching-Wei , Spoerke Jill M. , Yoh Kathryn E. , Kapoor Vidushi , Baudo Charles , Aimi Junko , Yu Mamie , Liang-Chu May M.Y. , Suttmann Rebecca , Huw Ling-Yuh , Gendreau Steven , Cummings Craig , Lackner Mark R.
Published: April 2023

Validation of LP-WGS in cfDNA from mBC patients.
Supplementary Information from VCAM-1–targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors
Authors: Cheng Vinton W.T. , Soto Manuel Sarmiento , Khrapitchev Alexandre A. , Perez-Balderas Francisco , Zakaria Rasheed , Jenkinson Michael D. , Middleton Mark R. , Sibson Nicola R.
Published: April 2023

Methods and 3 figures
Supplementary Data from Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy
Authors: De Angelis Carmine , Nagi Chandandeep , Hoyt Cliff C. , Liu Linying , Roman Kristin , Wang Chichung , Zheng Yi , Veeraraghavan Jamunarani , Sethunath Vidyalakshmi , Nuciforo Paolo , Wang Tao , Tsimelzon Anna , Mao Sufeng , Hilsenbeck Susan G. , Trivedi Meghana V. , Cataldo Maria Letizia , Pavlick Anne , Wolff Antonio C. , Weigelt Britta , Reis-Filho Jorge S. , Prat Aleix , Gutierrez Carolina , Osborne Charles Kent , Rimawi Mothaffar F. , Schiff Rachel
Published: April 2023

Supplementary tables
Supplementary Table 1 from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Authors: Jin Qi , Martinez Carlos A. , Arcipowski Kelly M. , Zhu Yixing , Gutierrez-Diaz Blanca T. , Wang Kenneth K. , Johnson Megan R. , Volk Andrew G. , Wang Feng , Wu Jian , Grove Charles , Wang Hui , Sokirniy Ivan , Thomas Paul M. , Goo Young Ah , Abshiru Nebiyu A. , Hijiya Nobuko , Peirs Sofie , Vandamme Niels , Berx Geert , Goosens Steven , Marshall Stacy A. , Rendleman Emily J. , Takahashi Yoh-hei , Wang Lu , Rawat Radhika , Bartom Elizabeth T. , Collings Clayton K. , Van Vlierberghe Pieter , Strikoudis Alexandros , Kelly Stephen , Ueberheide Beatrix , Mantis Christine , Kandela Irawati , Bourquin Jean-Pierre , Bornhauser Beat , Serafin Valentina , Bresolin Silvia , Paganin Maddalena , Accordi Benedetta , Basso Giuseppe , Kelleher Neil L. , Weinstock Joseph , Kumar Suresh , Crispino John D. , Shilatifard Ali , Ntziachristos Panagiotis
Published: April 2023

Supplementary Table 1
Figures S1-17 plus legends from USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Authors: Jin Qi , Martinez Carlos A. , Arcipowski Kelly M. , Zhu Yixing , Gutierrez-Diaz Blanca T. , Wang Kenneth K. , Johnson Megan R. , Volk Andrew G. , Wang Feng , Wu Jian , Grove Charles , Wang Hui , Sokirniy Ivan , Thomas Paul M. , Goo Young Ah , Abshiru Nebiyu A. , Hijiya Nobuko , Peirs Sofie , Vandamme Niels , Berx Geert , Goosens Steven , Marshall Stacy A. , Rendleman Emily J. , Takahashi Yoh-hei , Wang Lu , Rawat Radhika , Bartom Elizabeth T. , Collings Clayton K. , Van Vlierberghe Pieter , Strikoudis Alexandros , Kelly Stephen , Ueberheide Beatrix , Mantis Christine , Kandela Irawati , Bourquin Jean-Pierre , Bornhauser Beat , Serafin Valentina , Bresolin Silvia , Paganin Maddalena , Accordi Benedetta , Basso Giuseppe , Kelleher Neil L. , Weinstock Joseph , Kumar Suresh , Crispino John D. , Shilatifard Ali , Ntziachristos Panagiotis
Published: April 2023

Supplementary Figs. 1-17 with legends
Figure S2 from HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Authors: Courtney Kevin D. , Ma Yuanqing , Diaz de Leon Alberto , Christie Alana , Xie Zhiqun , Woolford Layton , Singla Nirmish , Joyce Allison , Hill Haley , Madhuranthakam Ananth J. , Yuan Qing , Xi Yin , Zhang Yue , Chang Jenny , Fatunde Oluwatomilade , Arriaga Yull , Frankel Arthur E. , Kalva Sanjeeva , Zhang Song , McKenzie Tiffani , Reig Torras Oscar , Figlin Robert A. , Rini Brian I. , McKay Renée M. , Kapur Payal , Wang Tao , Pedrosa Ivan , Brugarolas James
Published: April 2023

Supplementary Figure S2. PT2385 does not affect HIF-1 complexes.
Supplementary Table 3 from A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Authors: Teixeira Luis , Medioni Jacques , Garibal Julie , Adotevi Olivier , Doucet Ludovic , Durey Marie-Agnès Dragon , Ghrieb Zineb , Kiladjian Jean-Jacques , Brizard Mara , Laheurte Caroline , Wehbe Maria , Pliquet Elodie , Escande Marie , Defrance Rémy , Culine Stephane , Oudard Stephane , Wain-Hobson Simon , Doppler Valérie , Huet Thierry , Langlade-Demoyen Pierre
Published: April 2023

Number and percentage of patients reporting studytreatment-related AEs per cycle
Supplementary Table 1 from A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Authors: Teixeira Luis , Medioni Jacques , Garibal Julie , Adotevi Olivier , Doucet Ludovic , Durey Marie-Agnès Dragon , Ghrieb Zineb , Kiladjian Jean-Jacques , Brizard Mara , Laheurte Caroline , Wehbe Maria , Pliquet Elodie , Escande Marie , Defrance Rémy , Culine Stephane , Oudard Stephane , Wain-Hobson Simon , Doppler Valérie , Huet Thierry , Langlade-Demoyen Pierre
Published: April 2023

Flow Cytometry antibody references
Supplementary Figure 1 from A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Authors: Teixeira Luis , Medioni Jacques , Garibal Julie , Adotevi Olivier , Doucet Ludovic , Durey Marie-Agnès Dragon , Ghrieb Zineb , Kiladjian Jean-Jacques , Brizard Mara , Laheurte Caroline , Wehbe Maria , Pliquet Elodie , Escande Marie , Defrance Rémy , Culine Stephane , Oudard Stephane , Wain-Hobson Simon , Doppler Valérie , Huet Thierry , Langlade-Demoyen Pierre
Published: April 2023

Flow Chart
Data not shown from A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Authors: Teixeira Luis , Medioni Jacques , Garibal Julie , Adotevi Olivier , Doucet Ludovic , Durey Marie-Agnès Dragon , Ghrieb Zineb , Kiladjian Jean-Jacques , Brizard Mara , Laheurte Caroline , Wehbe Maria , Pliquet Elodie , Escande Marie , Defrance Rémy , Culine Stephane , Oudard Stephane , Wain-Hobson Simon , Doppler Valérie , Huet Thierry , Langlade-Demoyen Pierre
Published: April 2023

This file compiles all the results identified as "data not shown" in the manuscript
MESO-02 Trial Protocol from Ganetespib in Combination with Pemetrexed–Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial
Authors: Fennell Dean A. , Danson Sarah , Woll Penella J. , Forster Martin , Talbot Denis , Child Jennifer , Farrelly Laura , Sharkey Annabel , Busacca Sara , Ngai Yenting , Hackshaw Allan , Wheeler Graham M.
Published: April 2023

MESO-02 Trial Protocol (version 7.0)
Supplementary File 1 from Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non–Small Cell Lung Cancer In Vitro and In Vivo
Authors: Naz Sarwat , Sowers Anastasia , Choudhuri Rajani , Wissler Maria , Gamson Janet , Mathias Askale , Cook John A. , Mitchell James B.
Published: April 2023

excel file table showing details of microsatellite markers used for cell line authentication
Figure S3 from Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non–Small Cell Lung Cancer In Vitro and In Vivo
Authors: Naz Sarwat , Sowers Anastasia , Choudhuri Rajani , Wissler Maria , Gamson Janet , Mathias Askale , Cook John A. , Mitchell James B.
Published: April 2023

Figure S3. LC/MS analysis showing fold change in the expression of metabolites. H460 cells treated with Abemaciclib and 5Gy IR for 24 hours was taken for methanol extraction and subjected to LC/MS mass spectrometry analysis. Fold expression of each glycolytic and Tricarboxylic Acid (TCA) cycle intermediates (A) and Non-Essential and Essential amino acids (NEAA and EAA) are shown (B). Experiments were done in triplicates and error bar represent mean {plus minus} SD (standard deviation). *** p<0.0001.
Supplementary Figure 5 from Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
Authors: Seo Yongwoo David , Jiang Xiuyun , Sullivan Kevin M. , Jalikis Florencia G. , Smythe Kimberly S. , Abbasi Arezou , Vignali Marissa , Park James O. , Daniel Sara K. , Pollack Seth M. , Kim Teresa S. , Yeung Raymond , Crispe Ian Nicholas , Pierce Robert H. , Robins Harlan , Pillarisetty Venu G.
Published: April 2023

Live microscopy analysis of CD8+ T cell distribution in slice cultures
Supplementary Figure 4 from Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
Authors: Seo Yongwoo David , Jiang Xiuyun , Sullivan Kevin M. , Jalikis Florencia G. , Smythe Kimberly S. , Abbasi Arezou , Vignali Marissa , Park James O. , Daniel Sara K. , Pollack Seth M. , Kim Teresa S. , Yeung Raymond , Crispe Ian Nicholas , Pierce Robert H. , Robins Harlan , Pillarisetty Venu G.
Published: April 2023

Combination immunotherapy tumor slice culture experiment replicates
Supplementary Figure Legend from Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer
Authors: Hu-Lieskovan Siwen , Lisberg Aaron , Zaretsky Jesse M. , Grogan Tristan R. , Rizvi Hira , Wells Daniel K. , Carroll James , Cummings Amy , Madrigal John , Jones Benjamin , Gukasyan Jacklin , Shintaku I. Peter , Slamon Dennis , Dubinett Steven , Goldman Jonathan W. , Elashoff David , Hellmann Matthew D. , Ribas Antoni , Garon Edward B.
Published: April 2023

Supplementary Figure Legend
Supplementary Data from Activation of the Lysosome-Associated Membrane Protein LAMP5 by DOT1L Serves as a Bodyguard for MLL Fusion Oncoproteins to Evade Degradation in Leukemia
Authors: Wang Wen-Tao , Han Cai , Sun Yu-Meng , Chen Zhen-Hua , Fang Ke , Huang Wei , Sun Lin-Yu , Zeng Zhan-Cheng , Luo Xue-Qun , Chen Yue-Qin
Published: April 2023

Supplementary Figures including Fig. S1. Expression of LAMP5 in leukemia subtypesï¼ŒFig. S2. Knockdown of LAMP5 in MLL leukemia cellsï¼ŒFig. S3. LAMP5 regulated the apoptosis of MLL leukemia cellsï¼ŒFig. S4. LAMP5 regulates MLL leukemia progression in vivoï¼ŒFig. S5. LAMP5 regulates autophagy in MLL leukemia cellsï¼ŒFig. S6. LAMP5 was the target of DOT1L and susceptibility to DOT1L inhibitorï¼ŒFig. S7. Combination of DOT1L inhibitor and LAMP5-Knockdown suppresses leukemia progression
Supplementary Data from The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
Authors: Vaquero Javier , Lobe Cindy , Tahraoui Sylvana , Clapéron Audrey , Mergey Martine , Merabtene Fatiha , Wendum Dominique , Coulouarn Cédric , Housset Chantal , Desbois-Mouthon Christèle , Praz Françoise , Fouassier Laura
Published: April 2023

Supplementary Table 1. Human primers used for quantitative real-time PCR. Supplementary Table 2. Mouse primers used for quantitative real-time PCR. Supplementary Table 3. Human primers used for analysis of IR-A and IR-B isoforms by PCR visualized on gel electrophoresis. Supplementary Table 4. Primary antibodies used for immunodetection. Supplementary Table 5. Clinical and pathological characteristics of patients with CCA (n=10) Supplementary Table 6. Cancer stem cell-associated gene sets significantly enriched in the gene profiles of erlotinib-resistant cell lines. Supplementary Figure S1. Resistant CCA cells to EGFR inhibition display a down-regulation of activated EGFR and a lower sensitivity to erlotinib. Supplementary Figure S2. EGI-1 cells resistant to EGFR inhibition display increased migratory properties. Supplementary Figure S3. IGF2/IR/IGF1R axis is an escape route upregulated in CCA cells resistant to EGFR inhibition. Supplementary Figure S4. IR/IGF1R blockage regulates viability and cell plasticity of cholangiocarcinoma cells resistant to EGFR inhibition. Supplementary Figure S5. IR/IGF1R downregulation regulates viability and cell plasticity of cholangiocarcinoma cells resistant to EGFR inhibition. Supplementary Figure S6. Cholangiocarcinoma cells resistant to EGFR inhibition show increased tumorigenic potential and higher tumor stroma content. Supplementary Figure S7. Tumor cells and CAFs express IGF2 and IGF1R in human intrahepatic CCA. Supplementary Figure S8. IGF2/IR/IGF1R signaling regulates proliferation of hepatic myofibroblasts.
Supplementary Legend from Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma
Authors: Lorch Gwendolen , Sivaprakasam Karthigayini , Zismann Victoria , Perdigones Nieves , Contente-Cuomo Tania , Nazareno Alexandra , Facista Salvatore , Wong Shukmei , Drenner Kevin , Liang Winnie S. , Amann Joseph M. , Sinicropi-Yao Sara L. , Koenig Michael J. , La Perle Krista , Whitsett Timothy G. , Murtaza Muhammed , Trent Jeffrey M. , Carbone David P. , Hendricks William P.D.
Published: April 2023

Supplementary Legend
Figure S5 from Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma
Authors: Lorch Gwendolen , Sivaprakasam Karthigayini , Zismann Victoria , Perdigones Nieves , Contente-Cuomo Tania , Nazareno Alexandra , Facista Salvatore , Wong Shukmei , Drenner Kevin , Liang Winnie S. , Amann Joseph M. , Sinicropi-Yao Sara L. , Koenig Michael J. , La Perle Krista , Whitsett Timothy G. , Murtaza Muhammed , Trent Jeffrey M. , Carbone David P. , Hendricks William P.D.
Published: April 2023

HER2 expression in primary canine lung cancer based on quantitative real-time PCR analyses. Box plots are shown for HER2 2^(-Î"Î"Ct) expression fold-change relative to the housekeeping gene HPRT (x-axis) in 49 tumors and 14 matched normal lung tissues comparing (A) Normal lung tissue versus tumor tissue, and (B) Normal lung tissue versus HER2-wild-type tumor tissue versus HER2-mutant tumor tissue.
Figure S1b from The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients
Authors: Vozenin Marie-Catherine , De Fornel Pauline , Petersson Kristoffer , Favaudon Vincent , Jaccard Maud , Germond Jean-François , Petit Benoit , Burki Marco , Ferrand Gisèle , Patin David , Bouchaab Hanan , Ozsahin Mahmut , Bochud François , Bailat Claude , Devauchelle Patrick , Bourhis Jean
Published: April 2023

Figure S1B- Higher magnification showing the skin of the mini-pig 15 and 32 weeks post radiotherapy (RT). At 15 weeks, skin area irradiated with 31Gy-FLASH-RT shows hair regrowth but not with 31Gy-Conv-RT. At 32 weeks, skin area irradiated with 34Gy-FLASH-RT is healthy whereas contractile skin fibrosis is observed with 34 Gy-Conv-RT.
Figure S3 from Identification of Recurrent Activating HER2 Mutations in Primary Canine Pulmonary Adenocarcinoma
Authors: Lorch Gwendolen , Sivaprakasam Karthigayini , Zismann Victoria , Perdigones Nieves , Contente-Cuomo Tania , Nazareno Alexandra , Facista Salvatore , Wong Shukmei , Drenner Kevin , Liang Winnie S. , Amann Joseph M. , Sinicropi-Yao Sara L. , Koenig Michael J. , La Perle Krista , Whitsett Timothy G. , Murtaza Muhammed , Trent Jeffrey M. , Carbone David P. , Hendricks William P.D.
Published: April 2023

Somatic mutation signatures identified by exome sequencing in primary canine lung cancers. (A) The distribution of somatic single nucleotide mutation types in their trinucleotide context from tumor/normal exome sequencing of five cPAC cases. (B) The most common mutation signatures based on trinucleotide context and frequency of somatic single nucleotide mutations from tumor/normal exome sequencing of five cPAC cases. COSMIC Signature 1A (C>T substitutions at NpCpG trinucleotides that are associated with age) was present in four cases. COSMIC Signature 2 (C>T and C>G substitutions at TpCpN, associated with APOBEC cytidine deaminase activity) was present in two cases.
Figures S1-S6, Tables S1 - S3 from Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer
Authors: Moroz Anna , Wang Yung-Hua , Sharib Jeremy M. , Wei Junnian , Zhao Ning , Huang Yangjie , Chen Zhuo , Martinko Alexander J. , Zhuo Jie , Lim Shion A. , Zhang Lydia H. , Seo Youngho , Carlin Sean , Leung Kevin K. , Collisson Eric A. , Kirkwood Kimberly S. , Wells James A. , Evans Michael J.
Published: April 2023

Supplemental methods, figures, and tables
CD4+ T cell epitope prediction from Antibody-based Delivery of TNF to the Tumor Neovasculature Potentiates the Therapeutic Activity of a Peptide Anticancer Vaccine
Authors: Probst Philipp , Stringhini Marco , Ritz Danilo , Fugmann Tim , Neri Dario
Published: April 2023

Sequences from gp70 and results from the scoring against H2 I-Ad and H2 I-Ed position-specific scoring functions
Figure S1 from Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
Authors: Ayers Leona W. , Barbachano-Guerrero Arturo , McAllister Shane C. , Ritchie Julie A. , Asiago-Reddy Elizabeth , Bartlett Linda C. , Cesarman Ethel , Wang Dongliang , Rochford Rosemary , Martin Jeffrey N. , King Christine A.
Published: April 2023

Figures showing single stains in tissues
Supplementary Data from DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling
Authors: Li Jie , Pan Chaoyun , Boese Austin C. , Kang JiHoon , Umano Anna D. , Magliocca Kelly R. , Yang Wenqing , Zhang Yu , Lonial Sagar , Jin Lingtao , Kang Sumin
Published: April 2023

Supplementary Fig S3
Supplementary Data from DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling
Authors: Li Jie , Pan Chaoyun , Boese Austin C. , Kang JiHoon , Umano Anna D. , Magliocca Kelly R. , Yang Wenqing , Zhang Yu , Lonial Sagar , Jin Lingtao , Kang Sumin
Published: April 2023

Supplementary Fig S4
Supplementary Data from DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling
Authors: Li Jie , Pan Chaoyun , Boese Austin C. , Kang JiHoon , Umano Anna D. , Magliocca Kelly R. , Yang Wenqing , Zhang Yu , Lonial Sagar , Jin Lingtao , Kang Sumin
Published: April 2023

Supplementary Fig S6
Supplementary Figure S4 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S4
Supplementary Figure S3 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S3
Supplementary Figures and Tables from First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
Authors: Strauss Julius , Heery Christopher R. , Kim Joseph W. , Jochems Caroline , Donahue Renee N. , Montgomery Agnes S. , McMahon Sheri , Lamping Elizabeth , Marté Jennifer L. , Madan Ravi A. , Bilusic Marijo , Silver Matthew R. , Bertotti Elisa , Schlom Jeffrey , Gulley James L.
Published: April 2023

Supplementary Figures and Tables
Supplementary Figure S2 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S2
Supplementary Data from DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Authors: Adam Liana , San Lucas F. Anthony , Fowler Richard , Yu Yao , Wu Wenhui , Liu Yulun , Wang Huamin , Menter David , Tetzlaff Michael T. , Ensor Joe , Manyam Ganiraju , Arold Stefan T. , Huff Chad , Kopetz Scott , Scheet Paul , Overman Michael J.
Published: April 2023

Supplemental Figure 2
Supplementary Figure S17 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S17
Supplementary Data from DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Authors: Adam Liana , San Lucas F. Anthony , Fowler Richard , Yu Yao , Wu Wenhui , Liu Yulun , Wang Huamin , Menter David , Tetzlaff Michael T. , Ensor Joe , Manyam Ganiraju , Arold Stefan T. , Huff Chad , Kopetz Scott , Scheet Paul , Overman Michael J.
Published: April 2023

Table S2
Supplementary Figure S14 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
Authors: Tian Xiao-Peng , Su Ning , Wang Liang , Huang Wei-Juan , Liu Yan-Hui , Zhang Xi , Huang Hui-Qiang , Lin Tong-Yu , Ma Shu-Yun , Rao Hui-Lan , Li Mei , Liu Fang , Zhang Fen , Zhong Li-Ye , Liang Li , Lan Xiao-Liang , Li Juan , Liao Bing , Li Zhi-Hua , Tang Qiong-Lan , Liang Qiong , Shao Chun-Kui , Zhai Qiong-Li , Cheng Run-Fen , Sun Qi , Ru Kun , Gu Xia , Lin Xi-Na , Yi Kun , Shuang Yue-Rong , Chen Xiao-Dong , Dong Wei , Sun Cai , Sang Wei , Liu Hui , Zhu Zhi-Gang , Rao Jun , Guo Qiao-Nan , Zhou Ying , Meng Xiang-Ling , Zhu Yong , Hu Chang-Lu , Jiang Yi-Rong , Zhang Ying , Gao Hong-Yi , He Wen-Jun , Xia Zhong-Jun , Pan Xue-Yi , Hai Lan , Li Guo-Wei , Song Li-Yan , Kang Tie-Bang , Xie Dan , Cai Qing-Qing
Published: April 2023

Supplementary Figure S14
Supplementary Data Files from Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Authors: Tanioka Maki , Fan Cheng , Parker Joel S. , Hoadley Katherine A. , Hu Zhiyuan , Li Yan , Hyslop Terry M. , Pitcher Brandelyn N. , Soloway Matthew G. , Spears Patricia A. , Henry Lynn N. , Tolaney Sara , Dang Chau T. , Krop Ian E. , Harris Lyndsay N. , Berry Donald A. , Mardis Elaine R. , Winer Eric P. , Hudis Clifford A. , Carey Lisa A. , Perou Charles M.
Published: April 2023

Supplementary Data Files 1-12
Table S5 from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
Authors: Goodman Chelain R. , Seagle Brandon-Luke L. , Kocherginsky Masha , Donnelly Eric D. , Shahabi Shohreh , Strauss Jonathan B.
Published: April 2023

Sensitivity analysis for possible unmeasured confounding in the NCDB cohort.
Table S4 from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
Authors: Goodman Chelain R. , Seagle Brandon-Luke L. , Kocherginsky Masha , Donnelly Eric D. , Shahabi Shohreh , Strauss Jonathan B.
Published: April 2023

Kaplan-Meier estimates and covariate-adjusted unmatched parametric accelerated failure time models for overall survival from the SEER cohort.
Figure S1. Adjusted survival curves for the matched NCDB and SEER cohorts. from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
Authors: Goodman Chelain R. , Seagle Brandon-Luke L. , Kocherginsky Masha , Donnelly Eric D. , Shahabi Shohreh , Strauss Jonathan B.
Published: April 2023

Adjusted survival curves based on Kaplan-Meier estimates of overall survival for women within the matched cohorts of the Low-, Intermediate-, and High-Risk 21-gene Recurrence Score Assay diagnosed with T1-2 N1 ER-positive breast cancer treated with (blue) or without (red) post-mastectomy radiotherapy from the (A) NCDB and (B) SEER cohorts.
Table S1 from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework
Authors: Netterberg Ida , Karlsson Mats O. , Terstappen Leon W.M.M. , Koopman Miriam , Punt Cornelis J.A. , Friberg Lena E.
Published: April 2023

Baseline characteristics of the 451 patients included in the analysis data set
Figure S5 from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework
Authors: Netterberg Ida , Karlsson Mats O. , Terstappen Leon W.M.M. , Koopman Miriam , Punt Cornelis J.A. , Friberg Lena E.
Published: April 2023

VPC of the proportions of CTC count equal to 0, 1, 2, 3, >3 and {less than or equal to}5, >5 and {less than or equal to}10, >10 and {less than or equal to}50, >500 and {less than or equal to}100 and >100 over time in the final CTC model. The dots represent the observed proportions (connected with a line) and the shaded areas are the 95% CI of the simulated data, derived from 200 simulations from the final CTC model.
Figure S2 from Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework
Authors: Netterberg Ida , Karlsson Mats O. , Terstappen Leon W.M.M. , Koopman Miriam , Punt Cornelis J.A. , Friberg Lena E.
Published: April 2023

Schematic representation of the tumor size model. The total SLD is a sum of all compartments in the pink (drug sensitive fraction) and orange (drug resistant fraction) boxes.
Supplementary Table S2 from Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma
Authors: Lee Ju Youn , Schizas Michail , Geyer Felipe C. , Selenica Pier , Piscuoglio Salvatore , Sakr Rita A. , Ng Charlotte K.Y. , Carniello Jose V. Scarpa , Towers Russell , Giri Dilip D. , de Andrade Victor P. , Papanastasiou Anastasios D. , Viale Agnes , Harris Reuben S. , Solit David B. , Weigelt Britta , Reis-Filho Jorge S. , King Tari A.
Published: April 2023

Supplementary Table S2: Comparison of clonal relatedness of the lesions analyzed between Begg et al. (2), Sakr et al. (45) and this study.